United Therapeutics Chairperson, CEO Martine Rothblatt reports $4.61 million share disposal
UTHR•Martine Rothblatt exercised options for 9,500 United Therapeutics shares at $117.76 on Sept. 25, 2026, and a trust sold the same number that day at prices from $470.5565 to $478.9522. Trust holdings fell to 324,443 shares.
1. Options and share sale
United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised options for 9,500 shares at $117.76 on Sept. 25, 2026. A trust sold 9,500 shares in multiple trades that day at prices ranging from $470.5565 to $478.9522, leaving the trust with 324,443 shares.
